Dr. Hilal, MD, is a hematologist and medical oncologist specializing in bone marrow transplantation and cellular immunotherapy. He is an Associate Professor of Medicine at Mayo Clinic College of Medicine and Science, Program Director of the Hematology and Medical Oncology Fellowship Program at the Mayo Clinic School of Graduate Medical Education in Phoenix, and a consultant and staff physician in the Division of Hematology and Medical Oncology at Mayo Clinic Hospital. As physician faculty in the Bone Marrow Transplant and CAR T-Cell Therapy Programs, his clinical practice focuses on lymphoid malignancies, stem cell transplantation and cellular therapies, and rare hematologic disorders. His research interests include oncology clinical trial methodology and endpoint validation, real-world outcomes and toxicities of cellular immunotherapies, and the biology and targeted treatment of rare histiocytic disorders. He also serves as Chair of the Inpatient Practice Committee for the Division of Hematology/Oncology at Mayo Clinic in Arizona and as principal investigator and regional expert for the Histio-Care Network in Arizona. His honors include the Inspiring Excellence Award from the Royal College of Surgeons in Ireland – Medical University of Bahrain, the American Society of Hematology Abstract Achievement Award, the Resident Scholarly Activity Award at the University of Kentucky, and distinction as class valedictorian and gold medalist during medical school. Dr. Hilal earned his medical degree from the Royal College of Surgeons in Ireland – Medical University of Bahrain. He completed his residency in Internal Medicine at the University of Kentucky College of Medicine / Chandler Medical Center, followed by fellowship training in Hematology and Medical Oncology at Mayo Clinic College of Medicine and Science, where he also served as Chief Fellow.
Associate Professor
Medical School
2006 – 2012
Residency
2013 – 2016
Fellowship
2016 – 2019